CObalt chromium STent with Antiproliferation for Restenosis II Trial
ID Number 05-1305
Principal Investigator(s)Samin K. Sharma
Department(s) or Division(s)
Cardiology
Description
The purpose of this study is to demonstrate the efficacy of Costar Paclitaxel-Eluting Coronary Stent (investigational device) system compared to TAXUSTM Express2TM Drug Eluting Coronary Stent System.
Contact Information
Kameswari Vallabhajosyula NA
(212) 241-5696
kameswari.vallabhajosyula@msnyuhealth.org
Recruiting Patients: No

